Malaria
 
   
Contact Us
     

Malaria is a life-threatening parasitic infection transmitted to humans through the bites of infected female Anopheles mosquitoes. The resulting disease in humans can be devastating. In the absence of immunity or drug treatment, death can occur within hours of noticeable symptoms. Annually, 300 million to 500 million cases occur resulting in more than a million deaths. 90 % of these deaths occur in Africa, south of the Sahara and most of these victims are children under 5 years old. Pregnant women are also especially vulnerable.

There are a number of possible approaches to combat malaria, including mosquito control; limiting the chances for human exposure to the infected mosquito; prevention through prophylactic use of antimalarial drugs and hopefully one day trough use of vaccines.

Malaria Initiatives
 

sanofi-aventis DNDi Malaria Drug Development
A collaborative agreement to develop a new medicine against malaria.

GSK African Malaria Partnership
Through community development, this program helps nearly two million people in seven African countries fight malaria.

Novartis Coartem®
Novartis supplies, through WHO, Coartem® - the fastest-acting anti-malaria medicine, with a cure rate of over 95 percent.

JPMW Alliance (Japanese Pharmaceutical Companies, Japanese Ministry of Health, Labour and Welfare and WHO)
This public-private partnership is focused on developing new antimalarial drugs.

LAPDAP© Antimalarial Drug Development
The aim is to develop Lapdap© as a safe alternative to chloroquine and S-P, which are currently failing due to increased parasite resistance.

Malaria Vaccine Initiative (MVI)
MVI's mission is to accelerate the development of malaria vaccines and ensure their availability and accessibility to the developing world.

Medicines for Malaria Venture (MMV)
This program supports the discovery and development of new anti-malarial drugs suitable for use in developing countries.

Multilateral Initiative on Malaria (MIM)
MIM helps improve the abilities of malaria-endemic African countries to develop and improve tools for malaria control.

Roll Back Malaria Global Partnership (RBM)
RBM seeks to strengthen health systems to ensure better delivery of health care, especially at regional and community levels.
Initiatives by Region
 
Click on an area of the map to learn about regional health initiatives.